Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  esorubicin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 34 for your search:
Start Over
Phase III Chemotherapy with DTIC vs Therapy with the Single Most Active Agent Identified by Clonogenic Assay for Advanced Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 75
Sponsor:
Protocol IDs: UARIZ-1718H, NCI-V84-0058
Phase I/II Chemotherapy with 4'-Deoxydoxorubicin Administered on an Escalating Schedule in Patients with Previously Treated Stage IV Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: under physiologic 60
Sponsor: NCI
Protocol IDs: MTS-84040, NCI-T84-0235D, T84-0235
Phase I/II Chemotherapy with 4'-Deoxydoxorubicin Hydrochloride in Children with Malignant Solid Tumors (last Modified 11/87)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-DXDX1-2, NCI-T84-0439D, T84-0439
Phase I/II Chemotherapy with DxDx in Patients with Refractory Acute Leukemia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: AECM-8473, NCI-T84-0352D, T84-0352
Phase I/II Master Protocol Chemotherapy in Patients with Refractory Acute Leukemia and Chronic Myelogenous Leukemia in Blast Crisis --- 4'-Deoxydoxorubicin
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: over 15
Sponsor: NCI
Protocol IDs: CORN-8402, NCI-T84-0208W, T84-0208
Phase II Master Protocol for Evaluation of New Agents for Residual, Recurrent, or Metastatic Primary Liver Cancer --- Acivicin vs 4'-Deoxydoxorubicin
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2282
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Metastatic Renal Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-52883, NCI-T83-1413C, T83-1413
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Metastatic or Recurrent, Unresectable Adenocarcinoma of the Colon or Rectum
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-84I1, NCI-T84-0232D, T84-0232
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Unresectable or Recurrent non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: physiologic 70 and under
Sponsor: NCI
Protocol IDs: UMCC-8327, NCI-T84-0210W, T84-0210
Phase II First-Line Chemotherapy with 4'-Deoxydoxorubicin for Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-53984, NCI-T84-0193C, T84-0193
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Advanced Squamous Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-54184, NCI-T84-0209C, T84-0209
Phase II Chemotherapy with 4'-Deoxydoxorubicin in Previously Untreated Patients with Extensive Small Cell Lung Cancer plus VAC (VCR/ADR/CTX) or VP-16/CACP for Nonresponders
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: WSU-C-54484, NCI-T84-0276C, T84-0276
Phase II Chemotherapy with Esorubicin in Patients with Advanced Metastatic or Recurrent Epithelial Carcinoma of the Ovary
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8402
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Metastatic or Recurrent Endometrial Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8408
Phase II Chemotherapy with Esorubicin (4'-Deoxydoxorubicin) for Refractory Malignant Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8406
Phase II Chemotherapy with 4'-Deoxydoxorubicin in Previously Untreated Patients with Metastatic or Nonresectable Gastric Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHNMC-IRB-4133, NCI-T84-0266D, T84-0266
Phase II Chemotherapy with DxDx in Patients with Advanced Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MAYO-847002, NCI-T84-0376D, T84-0376
Phase II Chemotherapy with 4'-Deoxydoxorubicin in Patients with Nonresectable non-Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: ICC-84L1, NCI-T84-0295D, T84-0295
Phase II Master Protocol Chemotherapy with 4'-Deoxydoxorubicin for Advanced, Recurrent Pelvic Malignancies
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-26T
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Previously Untreated Locally Advanced or Metastatic Adenocarcinoma of the Pancreas
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: CHNMC-IRB-4118, CHNMC-L83-202, NCI-T84-0211D, T84-0211
Phase II Master Protocol Evaluation of Single-agent or Combination Chemotherapy for Advanced non-Small Cell Lung Cancer --- DxDx
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: CLB-8436, CALGB-8436
Phase II Chemotherapy with 4'-Deoxydoxorubicin for Advanced Breast, Colorectal, and Kidney Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: EORTC-04831
Phase II Chemotherapy with Deoxydoxorubicin for Advanced Gastrointestinal (Stomach, Pancreas, and Colorectal) Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 76
Sponsor:
Protocol IDs: EORTC-16825
Start Over